Key Decisions in HIV Care: Choosing ART in the Context of Virologic Failure and Resistance

Key Decisions in HIV Care: Choosing ART in the Context of Virologic Failure and Resistance

In this episode from the series “Key Decisions in HIV Care,” W. David Hardy, MD, and Josep M. Llibre, MD, PhD, discuss important considerations for ART use in the context of virologic failure and resistance, including:

  • A discussion of the definitions of the following: highly treatment experienced, complex ART, multidrug-resistant HIV, and limited treatment options
  • The scope of the problem, including data from the CNICS cohort
  • DHHS and EACS guideline recommendations on the management of virologic failure and drug resistance, including recommendations for the use of genotypic and phenotypic genotyping and proviral DNA sequencing
  • Construction of an optimized background regimen with discussion of the OPTIONS, DAWNING, NADIA, and VIKING-3 trials
  • Novel treatment options, including ibalizumab and data from TMB-301/-311, fostemsavir and data from BRIGHTE, and lenacapavir and data from CAPELLA

Presenters:

W. David Hardy, MD
Scientific and Medical Consultant
Adjunct Clinical Professor of Medicine
Division of Infectious Diseases
Keck School of Medicine of USC
Los Angeles, California

Josep M. Llibre, MD, PhD
S­enior Consultant Physician and Clinical Researcher
Infectious Disease and “Fight against AIDS and Infectious Diseases Foundation”
Hospital Universitari Germans Trias i Pujol
Badalona
Barcelona, Spain

Content based on an online CME program supported by educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; and ViiV Healthcare.

Follow along with the slides at:
https://bit.ly/3z9AtL0

Link to full program:
https://bit.ly/2TXTYWx


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(506)

Beyond the “Pneumonia Shot”: Explaining the Full Benefits of Pneumococcal Vaccines to Patients

Beyond the “Pneumonia Shot”: Explaining the Full Benefits of Pneumococcal Vaccines to Patients

Just as pneumonia isn’t “just a cold,” the pneumococcal vaccine does much more than just protect yourself or your child against pneumonia. Listen in and learn from experts Robert H. Hopkins, Jr., MD, ...

1 Heinä 21min

Heading Off Misinformation and Disinformation: Pressure Points in Pediatric Vaccines Podcast 3

Heading Off Misinformation and Disinformation: Pressure Points in Pediatric Vaccines Podcast 3

In the final episode of a 3-part series, featuring audio from a live symposium, experts Mary Koslap-Petraco, DNP, PPCNP, CPNP, FAANP, Patricia Stinchfield, MS, RN, PNP, and Jennifer M. Walsh, DNP, CPN...

18 Kesä 23min

Countering Myths and Mixed Messages: Pressure Points in Pediatric Vaccines Podcast 2

Countering Myths and Mixed Messages: Pressure Points in Pediatric Vaccines Podcast 2

In the second episode of a 3-part series featuring audio from a live symposium, experts Mary Koslap-Petraco, DNP, PPCNP, CPNP, FAANP, Patricia Stinchfield, MS, RN, PNP, and Jennifer M. Walsh, DNP, CPN...

18 Kesä 21min

Don’t You Wish You Pneumo? Why We Continue to Update Our Pneumococcal Vaccine Strategy

Don’t You Wish You Pneumo? Why We Continue to Update Our Pneumococcal Vaccine Strategy

Pneumococcal vaccine recommendations are constantly evolving to respond to shifting patterns of infections, which is a good thing. However, the nuances can be complicated to explain to patients. Liste...

5 Kesä 17min

DeLIVERing Prevention Podcast: Optimizing Uptake of Hepatitis A and B Vaccination

DeLIVERing Prevention Podcast: Optimizing Uptake of Hepatitis A and B Vaccination

Viral hepatitis is an ongoing public health threat, despite the long-standing availability of effective vaccines for hepatitis A and B. Here, experts Paul Kwo, MD, Jewel Mullen, MD, MPH, MPA, FACP, an...

1 Kesä 37min

Evolving ART Switch Options Podcast

Evolving ART Switch Options Podcast

Listen in to learn the latest on ART switch strategies for people living with virologically suppressed HIV. Hear from experts Chloe Orkin, MBChB, FRCP, MD, and Peter J. Ruane, MD, as they review how t...

15 Touko 28min

Advances in ART Podcast: Putting New Data on Emerging Options in Context

Advances in ART Podcast: Putting New Data on Emerging Options in Context

Listen now as experts, Chloe Orkin, MBChB, FRCP, MD, and Jihad Slim, MD, explore the potential clinical implications of new data on novel options for optimizing HIV therapy, especially for treatment-e...

8 Touko 23min

My Take on Hepatitis B Challenges in the African Immigrant Community

My Take on Hepatitis B Challenges in the African Immigrant Community

Listen as Bright Ansah, patient advocate, describes his experience with being diagnosed with chronic hepatitis B as a recent immigrant to the United States and the unique barriers to treatment faced b...

7 Touko 7min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
psykopodiaa-podcast
voi-hyvin-meditaatiot-2
rss-liian-kuuma-peruna
kesken
rss-luonnollinen-synnytys-podcast
rss-arkea-ja-aurinkoa-podcast-espanjasta
aamukahvilla
rss-narsisti
mielipaivakirja
ihminen-tavattavissa-tommy-hellsten-instituutti
rss-perho-rajoilla
rss-koira-haudattuna
rss-rahataito-podcast
rss-hereilla
rahapuhetta
solu-ja-molekyylibiologian-perusteet
rss-niinku-asia-on
ensihoidon-ja-pelastustyoncast
ilona-rauhala